Ranibizumab ELISA (mAb-based)

 

Enzyme immunoassay for the specific and quantitative determination of free Ranibizumab (Lucentis®) in aqueous humour.

The solid phase (MTP) is coated by a highly specific monoclonal antibody directed against Ranibizumab. Therefore any cross reactivity to the other therapeutical monoclonal antibodies is excluded except for Bevacizumab.

Reference: IG-AB110a

Barcode: 

Legal Status:

Intended Use: This kit has been developed for the measurement of drug levels in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.

Assay Design:

IG-AB110 Ranibizumab

Related Documents

Lucentis® is a trademark of ©2018 Genentech USA, Inc.

The Kit at a glance:

Required Volume (µL) 5
Incubation Time (min) 135
Sample aqueous humour
Package Size 96 Tests
Standard Range (ng/mL, 10x) 0-300
Detection Limit (ng/mL) 0,33
Spike Recovery (%) >95
Shelf Life (years) 2

Standard Curve:

IG-AB110a